Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Cash (2016 - 2025)

Historic Change in Cash for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $45.6 million.

  • AC Immune's Change in Cash rose 19227.07% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.7 million, marking a year-over-year increase of 25888.19%. This contributed to the annual value of -$46.3 million for FY2024, which is 18471.92% down from last year.
  • AC Immune's Change in Cash amounted to $45.6 million in Q3 2025, which was up 19227.07% from $9.7 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Change in Cash registered a high of $54.2 million during Q4 2023, and its lowest value of -$51.2 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Cash was -$11.6 million (2021), whereas its average is -$6.6 million.
  • In the last 5 years, AC Immune's Change in Cash crashed by 140862.36% in 2021 and then soared by 51477.88% in 2023.
  • AC Immune's Change in Cash (Quarter) stood at -$11.7 million in 2021, then dropped by 11.48% to -$13.1 million in 2022, then soared by 514.78% to $54.2 million in 2023, then crashed by 95.98% to $2.2 million in 2024, then skyrocketed by 1991.91% to $45.6 million in 2025.
  • Its last three reported values are $45.6 million in Q3 2025, $9.7 million for Q2 2025, and -$17.8 million during Q1 2025.